Ameriprise Financial Inc Charles River Laboratories International, Inc. Transaction History

Ameriprise Financial Inc

  • $375 Billion
  • Q4 2024

A detailed history of Ameriprise Financial Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 223,036 shares of CRL stock, worth $38.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
223,036
Previous 213,189 4.62%
Holding current value
$38.8 Million
Previous $42 Million 1.96%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$178.58 - $220.69 $1.76 Million - $2.17 Million
9,847 Added 4.62%
223,036 $41.2 Million
Q3 2024

Nov 14, 2024
SELL
$187.96 - $245.29 $27.9 Million - $36.5 Million
-148,660 Reduced 41.08%
213,189 $42 Million
Q2 2024

Aug 14, 2024
BUY
$206.39 - $268.73 $16.3 Million - $21.3 Million
79,113 Added 27.98%
361,849 $74.8 Million
Q1 2024

May 15, 2024
BUY
$203.52 - $273.43 $52.7 Million - $70.9 Million
259,151 Added 1098.8%
282,736 $76.6 Million
Q4 2023

Feb 14, 2024
SELL
$164.52 - $238.84 $233,124 - $338,436
-1,417 Reduced 5.67%
23,585 $5.58 Million
Q3 2023

Nov 14, 2023
BUY
$194.44 - $217.61 $289,715 - $324,238
1,490 Added 6.34%
25,002 $4.9 Million
Q2 2023

Aug 14, 2023
BUY
$183.71 - $210.25 $237,169 - $271,432
1,291 Added 5.81%
23,512 $4.94 Million
Q1 2023

May 15, 2023
SELL
$191.89 - $259.92 $56.9 Million - $77 Million
-296,276 Reduced 93.02%
22,221 $4.48 Million
Q4 2022

Feb 14, 2023
BUY
$197.11 - $250.07 $59.1 Million - $75 Million
299,953 Added 1617.52%
318,497 $69.4 Million
Q3 2022

Nov 14, 2022
SELL
$182.44 - $250.54 $201,231 - $276,345
-1,103 Reduced 5.61%
18,544 $3.65 Million
Q2 2022

Aug 15, 2022
SELL
$204.13 - $302.4 $1.43 Million - $2.12 Million
-7,019 Reduced 26.32%
19,647 $4.2 Million
Q1 2022

May 16, 2022
SELL
$255.51 - $362.11 $204,919 - $290,412
-802 Reduced 2.92%
26,666 $7.45 Million
Q4 2021

Feb 14, 2022
SELL
$351.38 - $448.68 $81.5 Million - $104 Million
-231,940 Reduced 89.41%
27,468 $10.3 Million
Q3 2021

Nov 15, 2021
SELL
$372.64 - $458.3 $217 Million - $267 Million
-581,623 Reduced 69.16%
259,408 $107 Million
Q2 2021

Aug 16, 2021
SELL
$294.17 - $371.65 $19.8 Million - $25.1 Million
-67,474 Reduced 7.43%
841,031 $311 Million
Q1 2021

May 17, 2021
SELL
$249.67 - $299.48 $60.3 Million - $72.3 Million
-241,402 Reduced 20.99%
908,505 $263 Million
Q4 2020

Feb 12, 2021
BUY
$222.0 - $252.62 $86.2 Million - $98.1 Million
388,345 Added 50.99%
1,149,907 $287 Million
Q3 2020

Nov 16, 2020
BUY
$175.56 - $226.45 $78.7 Million - $101 Million
448,012 Added 142.88%
761,562 $172 Million
Q2 2020

Aug 14, 2020
BUY
$118.84 - $189.72 $284,027 - $453,430
2,390 Added 0.77%
313,550 $54.6 Million
Q1 2020

May 15, 2020
SELL
$98.9 - $178.34 $13.5 Million - $24.3 Million
-136,109 Reduced 30.43%
311,160 $39.2 Million
Q4 2019

Feb 14, 2020
SELL
$126.05 - $152.76 $29.2 Million - $35.4 Million
-231,850 Reduced 34.14%
447,269 $68.3 Million
Q3 2019

Nov 14, 2019
BUY
$125.07 - $143.67 $13.9 Million - $16 Million
111,365 Added 19.62%
679,119 $89.9 Million
Q2 2019

Aug 14, 2019
BUY
$123.4 - $148.55 $17.6 Million - $21.2 Million
142,415 Added 33.48%
567,754 $80.6 Million
Q1 2019

May 15, 2019
BUY
$104.82 - $146.73 $7.37 Million - $10.3 Million
70,276 Added 19.79%
425,339 $61.8 Million
Q4 2018

Feb 14, 2019
SELL
$105.09 - $137.23 $2.23 Million - $2.91 Million
-21,240 Reduced 5.64%
355,063 $40.2 Million
Q3 2018

Nov 14, 2018
BUY
$112.11 - $134.54 $13.3 Million - $15.9 Million
118,496 Added 45.96%
376,303 $50.5 Million
Q2 2018

Aug 14, 2018
BUY
$102.37 - $117.25 $7.11 Million - $8.14 Million
69,463 Added 36.88%
257,807 $28.9 Million
Q1 2018

May 15, 2018
BUY
$98.19 - $115.2 $761,365 - $893,260
7,754 Added 4.29%
188,344 $20.1 Million
Q4 2017

Feb 12, 2018
SELL
$100.43 - $118.09 $527,960 - $620,799
-5,257 Reduced 2.83%
180,590 $19.8 Million
Q3 2017

Nov 07, 2017
BUY
$96.72 - $109.26 $18 Million - $20.3 Million
185,847
185,847 $20.1 Million

Others Institutions Holding CRL

# of Institutions
710
Shares Held
53.9M
Call Options Held
122K
Put Options Held
239K
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.84B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email